ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 070,48
0,10%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Theratechnologies Inc. (MM) (THER)

  7. Theratechnologies Inc. (MM) (THER) Actualités

THER

Therasense (THER)

Theratechnologies Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:THER
DateHeureSourceTitreSymboleSociété
03/12/202116h45GlobeNewswire Inc.Theratechnologies Europe riceve il premio "Innovation Business Award" nella categoria "Scienza e Salute" dall'ANGI, associazione Nazionale Giovani Innovatori per ibalizumabNASDAQ:THERTheratechnologies Inc. (MM)
26/10/202108h00GlobeNewswire Inc.THERATECHNOLOGIES ANNUNCIA IN ITALIA UN ACCORDO PER LA RIMBORSABILITA’ DI TROGARZO® PER I PAZIENTI CON INFEZIONE DA VIRUS HIV-1 MULTIRESISTENTENASDAQ:THERTheratechnologies Inc. (MM)
26/10/202108h00GlobeNewswire Inc.Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1NASDAQ:THERTheratechnologies Inc. (MM)
26/10/202108h00GlobeNewswire Inc.Theratechnologies annonce un accord de remboursement en Italie pour Trogarzo® pour les patients admissibles présentant une infection par le VIH-1 multirésistanteNASDAQ:THERTheratechnologies Inc. (MM)
30/09/202022h01GlobeNewswire Inc.Theratechnologies to Present at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5NASDAQ:THERTheratechnologies Inc. (MM)
30/09/202022h01GlobeNewswire Inc.Theratechnologies fera une présentation au H.C. Wainwright 4th Annual NASH Investor Conference le 5 octobre 2020NASDAQ:THERTheratechnologies Inc. (MM)
10/09/202008h00GlobeNewswire Inc.Theratechnologies annonce le lancement de Trogarzo(MD) en AllemagneNASDAQ:THERTheratechnologies Inc. (MM)
10/09/202008h00GlobeNewswire Inc.Theratechnologies Announces Launch of Trogarzo® in GermanyNASDAQ:THERTheratechnologies Inc. (MM)
07/11/201913h30GlobeNewswire Inc.Trogarzo® Remains Effective Close to a Decade After Treatment InitiationNASDAQ:THERTheratechnologies Inc. (MM)
07/11/201913h30GlobeNewswire Inc.Trogarzo(MD) demeure efficace près d’une décennie après le début du traitementNASDAQ:THERTheratechnologies Inc. (MM)
27/09/201914h28GlobeNewswire Inc.Europäische Kommission erteilt Zulassung für Trogarzo®NASDAQ:THERTheratechnologies Inc. (MM)
26/09/201920h13GlobeNewswire Inc.La Commission européenne approuve Trogarzo(MD)NASDAQ:THERTheratechnologies Inc. (MM)
26/09/201920h13GlobeNewswire Inc.European Commission Approves Trogarzo®NASDAQ:THERTheratechnologies Inc. (MM)
01/02/201315h03Edgar (US Regulatory)Certification of No Change in Definitive Materials. (497j)NASDAQ:THERTheratechnologies Inc. (MM)
01/02/201315h02Edgar (US Regulatory)Amended Annual Report (foreign Private Issuer) (40-f/a)NASDAQ:THERTheratechnologies Inc. (MM)
29/01/201316h55MarketwiredTheratechnologies Secures US Patent for its Novel Peptide TH1173NASDAQ:THERTheratechnologies Inc. (MM)
28/01/201320h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:THERTheratechnologies Inc. (MM)
28/01/201315h33Edgar (US Regulatory)Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)NASDAQ:THERTheratechnologies Inc. (MM)
28/01/201315h33Edgar (US Regulatory)(25)NASDAQ:THERTheratechnologies Inc. (MM)
21/01/201312h53MarketwiredTheratechnologies Inc.: FDA Approves Alternative Storage Conditions for EGRIFTA(TM)NASDAQ:THERTheratechnologies Inc. (MM)
14/01/201317h44Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:THERTheratechnologies Inc. (MM)
14/01/201317h44Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:THERTheratechnologies Inc. (MM)
14/01/201312h54MarketwiredTheratechnologies Announces Intent to Voluntarily Delist from NASDAQNASDAQ:THERTheratechnologies Inc. (MM)
30/10/201212h53MarketwiredTheratechnologies Inc.: Revenue Growth and Expenditure Control at the Core of Revised Business PlanNASDAQ:THERTheratechnologies Inc. (MM)
29/10/201212h30MarketwiredTheratechnologies to Host Conference CallNASDAQ:THERTheratechnologies Inc. (MM)
12/10/201200h13MarketwiredTheratechnologies Announces Departure of President and Chief Executive OfficerNASDAQ:THERTheratechnologies Inc. (MM)
11/10/201222h45MarketwiredTheratechnologies Announces Financial Results for Third Quarter of 2012NASDAQ:THERTheratechnologies Inc. (MM)
11/10/201216h00MarketwiredREMINDER/Theratechnologies to Announce Financial Results for Third Quarter of 2012NASDAQ:THERTheratechnologies Inc. (MM)
10/10/201213h30MarketwiredTheratechnologies Provides Follow-Up Regulatory Update on TesamorelinNASDAQ:THERTheratechnologies Inc. (MM)
03/10/201221h08MarketwiredTheratechnologies to Announce Financial Results for Third Quarter of 2012NASDAQ:THERTheratechnologies Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:THER

Dernières Valeurs Consultées

EU
PX1
CAC 40
SPI
SP500
S&P 500
EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
EU
PX4
SBF 120
USI
USTECH100
US Tech 100
NYSE
MRK
Merck
EU
GLE
Societe Generale
EU
AI
Air Liquide
EU
BEL20
Bel 20
NASDAQ
NVDA
NVIDIA
EU
AF
Air FranceKLM
NYSE
JPM
JP Morgan Chase
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés